分泌的脂酶A2组X调节对过敏原的外周敏感性
Ryan C Murphy1, Ying Lai1, Yu-Hua Chow1
1Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, United States of America.
JCI insight
|March 12, 2026
概括
分泌的脂酶A2组X (sPLA2-X) 作为辅助剂,促进过敏敏感化. 在敏感化过程中抑制sPLA2-X可降低气道过敏和炎症,提供潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 分子生物学分子生物学
背景情况:
- "阿托皮游行"描述了从过敏性皮肤病到过敏性呼吸道疾病的进展,其潜在的分子机制尚不清楚.
- 分泌的脂酶A2组X (sPLA2-X) 与人类的喘有关,并影响小鼠模型中的呼吸道过敏反应 (AHR) 和炎症.
研究的目的:
- 通过使用一种新型的蛋白质过敏原模型,研究sPLA2-X在"阿托皮游行"中的作用.
- 确定sPLA2-X是否促进了外周过敏原敏感化和随后的呼吸道功能障碍.
主要方法:
- 开发了一种模仿"atopic march"的小鼠模型,使用室内灰尘虫 (HDM) 进行皮肤敏感化和呼吸道挑战.
- 使用了sPLA2-X淘汰赛 (Pla2g10-/-) 的小鼠和表达人类sPLA2-X.的转基因小鼠.
- 在敏感化阶段使用sPLA2-X的小分子抑制剂 (ROC0929).
主要成果:
- 与野生型 (WT) 小鼠相比,Pla2g10-/-小鼠在HDM敏感化和挑战后表现出降低的AHR和下呼吸道乙氨基酸细胞数量.
- 在敏感化过程中对转基因小鼠的sPLA2-X抑制导致了减弱的AHR.
- sPLA2-X抑制减少了肺组织的过敏原特异性记忆CD4+T细胞.
结论:
- sPLA2-X作为一种内源辅助剂,增强了外围过敏敏感性.
- 在敏感化阶段准sPLA2-X可以调节随后的过敏原诱导的呼吸道功能障碍,包括AHR和炎症.
- 这些发现支持sPLA2-X抑制作为预防或治疗过敏呼吸道疾病的潜在策略.
相关概念视频
Allergic Reactions
33.3K
Overview
33.3K
Asthma-II: Pathophysiology and Classification
4.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
IP3/DAG Signaling Pathway
15.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.5K
Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Allergic Reactions: Anaphylaxis
111
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
111
GPCRs Regulate Adenylyl Cylase Activity
8.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.0K


